The abstract is read at the publisher; the summary is JClub's.
Higher epithelial ITLN1 expression in treatment-naïve human colorectal cancer is linked to greater neutrophil infiltration, shorter mature neutrophil–tumor epithelial distances, and improved survival.
- Why it matters: ITLN1 is often downregulated in colorectal cancer, but its role in shaping spatial, anti-tumor neutrophil immunity was unclear.
- What they did: The study combined multiplex immunohistochemistry, spatial analysis, single-cell transcriptomics, chromatin accessibility, and perturbation models, including Itln1 silencing in mouse colorectal cancer and recombinant ITLN1 rescue.
- The result: In mice, Itln1 silencing accelerates tumor growth and metastasis and disrupts CXCR2+ CD101+ mature neutrophil generation and recruitment, while recombinant ITLN1 restores maturation and tumor-killing via a JAK1/STAT3-associated C/EBPβ program.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.